Cited by 2,251Clinical practice guidelines implementationHealth Promotion and Cardiovascular PreventionCoronary Interventions and Diagnostics

The DOI matches its Crossref record.

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

De Backer, G·2003·European Heart Journal

DOI 10.1016/s0195-668x(03)00347-6

Open this paper in CoChat — free account

Abstract

Guidelines aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decision-making. A great number of guidelines have been issued in recent years by different organizations-European Society of Cardiology (ESC), American Heart Association (AHA), American College of Cardiology (ACC), and other related societies. By means of links to web sites of National Societies several hundred guidelines are available. This profusion can put at stake the authority and validity of guidelines, which can only be guaranteed if they have been developed by an unquestionable decision-making process. This is one of the reasons why the ESC and others have issued recommendations for formulating and issuing guidelines. In spite of the fact that standards for issuing good quality guidelines are well defined, recent surveys of guidelines published in peer-reviewed journals between 1985 and 1998 have shown that methodological standards were not complied with in the vast majority of cases. It is therefore of great importance that guidelines and recommendations are presented in formats that are easily interpreted. Subsequently, their implementation programmes must also be well conducted. Attempts have been made to determine whether guidelines improve the quality of clinical practice and the utilization of health resources. In addition, the legal implications of medical guidelines have been discussed and examined, resulting in position documents, which have been published by a specific Task Force.

Integrity signals

Registry

Crossref · 10.1016/s0195-668x(03)00347-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 101–200 of 999

Physical Activity and Incident Cognitive Impairment in Elderly Persons
Etgen, T. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.498 · Cited by 252
Factors associated with non-participation in and dropout from cardiac rehabilitation programmes: a systematic review of prospective cohort studies
Resurrección, D. M., Moreno-Peral, P., Gómez-Herranz, M., Rubio-Valera, M., Pastor, L., Caldas‐de‐Almeida, J. M., & Motrico, E. (2018) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515118783157 · Cited by 252
Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)
Nicholls, S. J., Brandrup‐Wognsen, G., Palmer, M. K., & Barter, P. J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.08.651 · Cited by 251
Association between Erectile Dysfunction and Coronary Artery Disease: Matching the Right Target with the Right Test in the Right Patient
Montorsi, P., Ravagnani, P. M., Galli, S., Salonia, A., Briganti, A., Werba, J. P., & Montorsi, F. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.015 · Cited by 236
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
Friis‐Møller, N., Ryom, L., Smith, C. J., Weber, R. K., Reiss, P., Dabis, F., Wit, S. D., Monforte, A. D., Kirk, O., Fontas, É., et al. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315579291 · Cited by 242
Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease
Emberson, J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.012 · Cited by 244
Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors
Vasan, R. S., SULLIVAN, L. M., Wilson, P. W. F., Sempos, C. T., Sundström, J., Kannel, W. B., Levy, D. A., & D’Agostino, R. B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00005 · Cited by 234
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., Reiner, Ž., Keil, U., & EUROASPIRE Study Group (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283383f30 · Cited by 238
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Casas, J. P., Cavalleri, G. L., Bautista, L. E., Smeeth, L. L., Humphries, S. E., & Hingorani, A. D. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj302 · Cited by 236
Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE)
Deedwania, P., Stone, P. H., Bairey Merz, C. N., Cosin-Aguilar, J., Koylan, N., Luo, D., Ouyang, P., Piotrowicz, R., Schenck-Gustafsson, K., Sellier, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.654756 · Cited by 236
Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up
Langsted, A., Freiberg, J., Tybjærg‐Hansen, A., Schnohr, P., Jensen, G. B., & Nordestgaard, B. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02333.x · Cited by 234
Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial
Panahi, Y., Khalili, N., Hosseini, M. S., Abbasinazari, M., & Sahebkar, A. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.07.006 · Cited by 231
Sudden Cardiac Death in Young Athletes
Chandra, N., Bastiaenen, R., Papadakis, M., & Sharma, S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1032 · Cited by 229
Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study
Hippisley‐Cox, J., Coupland, C. A. C., Vinogradova, Y., Robson, J. P., & Brindle, P. M. (2007) · Heart · doi:10.1136/hrt.2007.134890 · Cited by 226
How Evidence-Based Are the Recommendations in Evidence-Based Guidelines?
McAlister, F. A., van Diepen, S., Padwal, R. S., Johnson, J. A., & Majumdar, S. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040250 · Cited by 226
Calcification in atherosclerosis
Alexopoulos, N. A., & Raggi, P. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.165 · Cited by 231
Expert review on coronary calcium
Budoff, M. J. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1160 · Cited by 222
Knowledge Gaps in Cardiovascular Care of the Older Adult Population
Rich, M. W., Chyun, D. A., Skolnick, A. H., Alexander, K. P., Forman, D. E., Kitzman, D. W., Maurer, M. S., McClurken, J. B., Resnick, B. M., Shen, W. K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000380 · Cited by 225
Family Health Behaviors
Fadlon, I., & Nielsen, T. H. (2019) · American Economic Review · doi:10.1257/aer.20171993 · Cited by 221
Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease
Rana, J. S., Nieuwdorp, M., Jukema, J. W., & Kastelein, J. J. P. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00594.x · Cited by 212
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Capodanno, D., Mehran, R., Valgimigli, M., Baber, U., Windecker, S., Vranckx, P., Dangas, G., Rollini, F., Kimura, T., Collet, J., et al. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0049-1 · Cited by 220
Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects
Laufs, U., Urhausen, A. J. P., Werner, N., Scharhag, J., Heitz, A., Kissner, G., Böhm, M., Kindermann, W., & Nickenig, G. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000174823.87269.2e · Cited by 212
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and A po B in patients undergoing primary prevention of cardiovascular disease: A triple‐blind, 6‐month follow‐up, placebo‐controlled, randomized trial
Tomé‐Carneiro, J., Gonzálvez, M., Larrosa, M., García‐Almagro, F. J., Avilés-Plaza, F. V., Parra, S., Yáñez-Gascón, M. J., Ruiz‐Ros, J. A., García‐Conesa, M., Tomás-Barberán, F. A., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100673 · Cited by 211
Omega-3 fatty acids and cardiovascular disease
von Schacky, C. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3280127af0 · Cited by 207
Long-term effects of two psychological interventions on physical exercise and self-regulation following coronary rehabilitation
Sniehotta, F. F., Scholz, U., Schwarzer, R., Fuhrmann, B., Kiwus, U., & Völler, H. (2005) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1204_5 · Cited by 201
Exercise prescription in patients with different combinations of cardiovascular disease risk factors: a consensus statement from the EXPERT Working Group
Hansen, D., Niebauer, J., Cornelissen, V., Barna, O., Neunhäuserer, D., Stettler, C., Tonoli, C., Greco, E., Fagard, R., Coninx, K., et al. (2018) · Sports Medicine · doi:10.1007/s40279-018-0930-4 · Cited by 191
The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials
Josan, K., Majumdar, S. R., & McAlister, F. A. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070675 · Cited by 197
Revisiting Rose: strategies for reducing coronary heart disease
Manuel, D. G., Lim, J., Tanuseputro, P., Anderson, G. M., Alter, D. A., Laupacis, A., & Mustard, C. A. (2006) · BMJ · doi:10.1136/bmj.332.7542.659 · Cited by 195
Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
Rosenzweig, J. L., Ferrannini, E., Grundy, S. M., Haffner, S. M., Heine, R. J., Horton, E. S., & Kawamori, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0222 · Cited by 197
Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: The Cardiovascular Risk in Young Finns Study
Juonala, M., Kähönen, M. A. P., Laitinen, T. P., Hutri‐Kähönen, N., Jokinen, E., Taittonen, L. M., Pietikainen, M., Helenius, H. Y. M., Viikari, J. S. A., & Raitakari, O. T. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm556 · Cited by 190
AcroBel – the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects
Bex, M., Abs, R., T'Sjoen, G. G., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0358 · Cited by 190
Potential role of polycyclic aromatic hydrocarbons as mediators of cardiovascular effects from combustion particles
Holme, J. A., Brinchmann, B. C., Refsnes, M., Låg, M., & Øvrevik, J. (2019) · Environmental Health · doi:10.1186/s12940-019-0514-2 · Cited by 194
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
Mancia, G., Schumacher, H., Redón, J., Verdecchia, P., Schmieder, R. E., Jennings, G., Yusoff, K., Rydén, L., Liu, G. L., Teo, K. K., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008870 · Cited by 185
Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort Studies
Qu, X., Jin, F., Hao, Y., Li, H., Tang, T., Wang, H., Yan, W., & Dai, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057720 · Cited by 190
How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation
Cuende, J. I., Cuende, N., & Calaveras-Lagartos, J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq205 · Cited by 182
Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene
Naoumova, R. P., Tosi, I., Patel, D., Neuwirth, C. K. Y., Horswell, S. D., Marais, A. D., van Heyningen, C., & Soutar, A. K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190668.94752.ab · Cited by 185
The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study.
Brindle, P. M., McConnachie, A., Upton, M. N., Hart, C., Smith, G. D., & Watt, G. C. M. (2005) · Europe PMC (PubMed Central) · Cited by 182
Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain
Grau, M., Subirana, I., Elosúa, R., Solanas, P., Ramos, R., Masià, R., Cordón, F., Sala, J., Juvinyà, D., Cerezo, C., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3281764429 · Cited by 177
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization
Lenzen, M. J., Boersma, E. H., Bertrand, M. E., Maier, W., Morı́s, C., Piscione, F., Sechtem, U. P., Ståhle, E., Widimský, P., de Jaegere, P. P. T., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi238 · Cited by 179
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
Collins, P. D., Rosano, G. M. C., Casey, C., Daly, C., Gambacciani, M., Hadji, P., Kaaja, R., Mikkola, T. S., Palacios, S., Preston, R. A., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm296 · Cited by 178
Chemical and nutritional characteristics of brown seaweed lipids: A review
Miyashita, K., Mikami, N., & Hosokawa, M. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2013.09.019 · Cited by 179
Beyond Low-Density Lipoprotein
Nesto, R. W. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505060-00005 · Cited by 176
Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study
Wang, H., Leineweber, C., Kirkeeide, R. L., Svane, B., Schenck-Gustafsson, K. G., Theorell, T., & Orth‐Gomér, K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01759.x · Cited by 173
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries
Kotseva, K., Backer, G. D., Bacquer, D. D., Rydén, L., Hoes, A. W., Grobbee, D. E., Maggioni, A. P., Marques-Vidal, P. M., Jennings, C. S., Abreu, A., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320908698 · Cited by 184
Self-citation
Effects of dietary polyphenols on gene expression in human vascular endothelial cells
Nicholson, S. K., Tucker, G. A., & Brameld, J. M. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108006009 · Cited by 170
Barriers to apply cardiovascular prediction rules in primary care: a postal survey
Eichler, K., Zoller, M., Tschudi, P., & Steurer, J. (2007) · BMC Family Practice · doi:10.1186/1471-2296-8-1 · Cited by 167
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group (2004) · Diabetologia · doi:10.1007/s00125-004-1574-5 · Cited by 170
Patient Knowledge of Coronary Risk Profile Improves the Effectiveness of Dyslipidemia Therapy
Grover, S. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.21.2296 · Cited by 171
Rationale, design, methods and baseline characteristics of the Asklepios Study
Rietzschel, E., Buyzere, M. D., Bekaert, S., Segers, P., Bacquer, D. D., Cooman, L., Damme, P. V., Cassiman, P., Langlois, M. R., Oostveldt, P. V., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328012c380 · Cited by 167
Self-citation
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart
Lenzen, M. J., Rydén, L., Öhrvik, J., Bartnik, M., Malmberg, K., Reimer, W. J. M. S. O., Simoons, M. L., & on behalf of the Euro Heart Survey Investigators (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl363 · Cited by 164
The Framingham Heart Study's Impact on Global Risk Assessment
Bitton, A., & Gaziano, T. A. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.04.001 · Cited by 164
Contemporary Management of Dyslipidemia in High-Risk Patients: Targets Still Not Met
Yan, A. T.-K., Yan, R. T., Tan, M., Hackam, D. G., Leblanc, K., Kertland, H. R., Tsang, J. L. Y., Jaffer, S., Kates, M. L., Leiter, L. A., et al. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.015 · Cited by 159
Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk)
Khaw, K., Bingham, S. A., Welch, A. A., Luben, R., O'Brien, E. T., Wareham, N. J., & Day, N. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1397 · Cited by 156
Antiarrhythmic effects of omega-3 fatty acids
Reiffel, J. A., & McDonald, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.027 · Cited by 153
The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
Speyer, H., Christian Brix Nørgaard, H., Birk, M., Karlsen, M., Storch Jakobsen, A., Pedersen, K., Hjorthøj, C., Pisinger, C., Gluud, C., Mors, O., et al. (2016) · World Psychiatry · doi:10.1002/wps.20318 · Cited by 153
Obesity, Behavioral Lifestyle Factors, and Risk of Acute Coronary Events
Jensen, M. K., Chiuve, S. E., Rimm, E. B., Dethlefsen, C., Tjønneland, A. M., Joensen, A. M., & Overvad, K. (2008) · Circulation · doi:10.1161/circulationaha.107.759951 · Cited by 152
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
Olivera, P. A., Zuily, S., Kotze, P. G., Regnault, V., Awadhi, S. A., Bossuyt, P. J., Gearry, R. B., Ghosh, S. K., Kobayashi, T., Lacolley, P. J., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00492-8 · Cited by 154
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
Backer, G. D., Ambrosio, G., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · PubMed · doi:10.1097/01.hjr.0000087913.96265.e2 · Cited by 153
Self-citation
Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era
Pérez-López, F. R., Chedraui, P. A., Gilbert, J. J., & Pérez‐Roncero, G. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.032 · Cited by 151
Lifetime Risks for Cardiovascular Disease Mortality by Cardiorespiratory Fitness Levels Measured at Ages 45, 55, and 65 Years in Men
Berry, J. D., Willis, B. L., Gupta, S. K., Barlow, C. E., Gilchrist, S. C., Khera, A., Rohatgi, A. K., de Lemos, J. A., Haskell, W. L., & Lloyd‐Jones, D. M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.056 · Cited by 149
A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors The Björknäs study
Eriksson, M. K., Westborg, C.-J., & Eliasson, M. (2006) · Scandinavian Journal of Public Health · doi:10.1080/14034940500489826 · Cited by 146
Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings
Mendis, S., Lindholm, L. H., Anderson, S. G., Alwan, A., Koju, R., Onwubere, B., Kayani, A. M., Abeysinghe, N., Duneas, A., Tabagari, S., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.02.001 · Cited by 145
Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries
von Birgelen, C., Hartmann, M., Mintz, G. S., van Houwelingen, K. G., Deppermann, N., Schmermund, A., Böse, D., Eggebrecht, H., Neumann, T., Gössl, M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142048.94084.ca · Cited by 144
Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density LipoproteinCholesterolLevelsonaBackgroundofAtorvastatin
McKenney, J. M., Davidson, M. H., Shear, C. L., & Revkin, J. H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.066 · Cited by 144
South African hypertension guideline 2006.
Seedat, Y. K., Ma, C., Milne, F. J., Opie, L. H., Vj, P.-A., Rayner, B. L., & Veriava, Y. (2006) · PubMed · Cited by 141
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients
Clayton, T. C., Lubsen, J. C., Pocock, S., Vokó, Z., Kirwan, B., Fox, K. A. A., & Poole-Wilson, P. A. (2005) · BMJ · doi:10.1136/bmj.38603.656076.63 · Cited by 140
Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol
Schmidt‐Lucke, C., Fichtlscherer, S., Aicher, A., Tschöpe, C., Schultheiss, H., Zeiher, A. M., & Dimmeler, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013790 · Cited by 144
Novel biomarkers of cardiovascular disease: Applications in clinical practice
Lyngbakken, M. N., Myhre, P. L., Røsjø, H. R., & Omland, T. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1525335 · Cited by 155
Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs
Eddy, D. M., Adler, J. S., Patterson, B., Lucas, D., Smith, K. A., & Morris, M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00008 · Cited by 139
Mediterranean and carbohydrate-restricted diets and mortality among elderly men: a cohort study in Sweden
Sjögren, P., Becker, W., Warensjö, E., Olsson, E., Byberg, L., Gustafsson, I., Karlström, B., & Cederholm, T. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29345 · Cited by 143
Enzymatic Fuel Cells: Towards Self-Powered Implantable and Wearable Diagnostics
Gonzalez-Solino, C., & Lorenzo, M. D. (2018) · Biosensors · doi:10.3390/bios8010011 · Cited by 142
SLÁN 2007: Survey of Lifestyle, Attitudes and Nutrition in Ireland: Main Report
Morgan, K., McGee, H. M., Watson, D., Perry, I. J., Barry, M. M., Shelley, E., Harrington, J. M., Molcho, M., Layte, R., Van Lente, E., et al. (2008) · ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) · doi:10.13025/21992 · Cited by 140
The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%
Franco, O. H., Bonneux, L., Laet, C. E. D. H. D., et al. (2004) · BMJ · doi:10.1136/bmj.329.7480.1447 · Cited by 139
Importance of characteristics and modalities of physical activity and exercise in defining the benefits to cardiovascular health within the general population: recommendations from the EACPR (Part I)
Vanhees, L., SUTTER, J. D., Geladas, N. D., Doyle, F., Prescott, E., Cornelissen, V., Kouidi, E. J., Dugmore, D., Vanuzzo, D., Börjesson, M., et al. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312437059 · Cited by 145
Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography
Schmermund, A., Möhlenkamp, S., Berenbein, S., Pump, H., Moebus, S., Roggenbuck, U., Stang, A., Seibel, R. M. M., Grönemeyer, D. H. W., Jöckel, K., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.003 · Cited by 137
Psychosocial interventions for smoking cessation in patients with coronary heart disease
Barth, J., Jacob, T., Daha, I. C., & Critchley, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006886.pub2 · Cited by 143
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
Chapman, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.003 · Cited by 138
Incremental Predictive Value of Carotid Ultrasonography in the Assessment of Coronary Risk in a Cohort of Asymptomatic Type 2 Diabetic Subjects
Bernard, S., Sérusclat, A., Targe, F., Charrière, S., Roth, O., Beaune, J., Berthézène, F., & Moulin, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1158 · Cited by 131
Safety of rosuvastatin
Shepherd, J., Hunninghake, D. B., Stein, E. A., Kastelein, J. J. P., Harris, S., Pears, J. S., & Hutchinson, H. G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.049 · Cited by 137
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality
Doran, B., Guo, Y., Xu, J., WEINTRAUB, H. S., Mora, S., Maron, D. J., & Bangalore, S. (2014) · Circulation · doi:10.1161/circulationaha.114.010001 · Cited by 135
Role of Prescription Omega‐3 Fatty Acids in the Treatment of Hypertriglyceridemia
McKenney, J. M., & Sica, D. A. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.5.715 · Cited by 131
Discontinuation of statin therapy following an acute myocardial infarction: a population-based study
Daskalopoulou, S. S., Delaney, J. A., Filion, K. B., Brophy, J. M., Mayo, N. E., & Suissa, S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn346 · Cited by 134
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
Toms, T. E., Panoulas, V. F., Douglas, K., Griffiths, H. R., Sattar, N. A., Smith, J. P., Symmons, D. P. M., Nightingale, P., Metsios, G. S., & Kitas, G. D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.115717 · Cited by 132
Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome
Grassi, G. M. (2006) · Hypertension Research · doi:10.1291/hypres.29.839 · Cited by 131
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH
Oreopoulos, A., McAlister, F. A., Kalantar‐Zadeh, K., Padwal, R. S., Ezekowitz, J. A., Sharma, A., Kovesdy, C. P., Fonarow, G. C., & Norris, C. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp288 · Cited by 134
Diagnosis and management of the metabolic syndrome in obesity
Liberopoulos, E. N., Mikhailidis, D. P., & Elisaf, M. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00221.x · Cited by 131
Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study
Etgen, T., Sander, D., Chonchol, M., Briesenick, C., Poppert, H., Förstl, H., & Bickel, H. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp230 · Cited by 131
The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003
Eliasson, B., Cederholm, J., Nilsson, P. M., & Guðbjörnsdóttir, S. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01648.x · Cited by 128
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
Sasso, F. C., Pafundi, P. C., Simeon, V., Nicola, L. D., Chiodini, P., Galiero, R., Rinaldi, L., Nevola, R., Salvatore, T., Sardu, C., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01343-1 · Cited by 130
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management
Lip, G. Y. H., Barnett, A. H., Bradbury, A. W., Cappuccio, F. P., Gill, P. S., Hughes, E. A., Imray, C., Jolly, K. B., & Patel, K. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002126 · Cited by 132
Type 2 diabetes and cardiovascular disease in women
Norhammar, A., & Schenck-Gustafsson, K. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2694-y · Cited by 128
Cardiovascular Aspects of Sexual Medicine
Jackson, G., Montorsi, P., Adams, M. A., Anis, T. H., El‐Sakka, A. I., Miner, M. M., Vlachopoulos, C. V., & Kim, E. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01779.x · Cited by 126
Imaging of coronary atherosclerosis by computed tomography
Achenbach, S. S., & Raggi, P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq150 · Cited by 128
Electronic Alerts Versus On-Demand Decision Support to Improve Dyslipidemia Treatment
van Wyk, J. T., van Wijk, M. A. M., Sturkenboom, M., Mosseveld, M., Moorman, P. W., & van der Lei, J. (2008) · Circulation · doi:10.1161/circulationaha.107.697201 · Cited by 124
Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups
Brindle, P., May, M., Gill, P. S., Cappuccio, F. P., D’Agostino, R. B., Fischbacher, C., & Ebrahim, S. B. J. (2006) · Heart · doi:10.1136/hrt.2006.092346 · Cited by 123
Health related quality of life in coronary patients and its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey
Smedt, D. D., Clays, E., Annemans, L., Doyle, F., Kotseva, K., Pająk, A., Prugger, C., Jennings, C. S., Wood, D., & Bacquer, D. D. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.053 · Cited by 122
Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies
Bots, M. L. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x148472 · Cited by 121
Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals
Simon, A. C., Chironi, G. N., & Levenson, J. A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm487 · Cited by 118
Subclinical Coronary and Aortic Atherosclerosis Detected by Magnetic Resonance Imaging in Type 1 Diabetes With and Without Diabetic Nephropathy
Kim, W. Y., Astrup, A. S., Stuber, M., Tarnow, L., Falk, E., Botnar, R. M., Simonsen, C., Pietraszek, L., Hansen, P. R., Manning, W. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.633339 · Cited by 120
A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis
Patel, T. N., Shishehbor, M. H., & Bhatt, D. L. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl445 · Cited by 119

Authors: De Backer, G.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2003-09
Volume: 24
Issue: 17
Pages: 1601-1610
ISSN: 0195-668X (ISSN-L)
DOI: 10.1016/s0195-668x(03)00347-6
OpenAlex: W2153788691
Cited by: 2,251
References: 0
Citations by year: 2026: 4 · 2025: 7 · 2024: 15 · 2023: 19 · 2022: 12 · 2021: 55 · 2020: 64 · 2019: 92 · 2018: 65 · 2017: 67 · 2016: 51 · 2015: 57 · 2014: 78 · 2013: 87 · 2012: 98
FWCI: 206.41
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords: cardiovascular disease prevention, guideline development methodology, quality of evidence, clinical decision-making, guideline implementation, cardiovascular risk management
MeSH terms: Smoking Prevention, Blood Pressure, Cardiovascular Diseases, Diagnostic Imaging, Diet, Europe, Health Priorities, Humans, Lipids, Risk Factors, Exercise, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks